Monday, October 24, 2016: 5:30 PM - 7:00 PM
Stanley Park Ballroom 123, Second Floor (Westin Bayshore Vancouver)

Since publication of the report of the Panel on Cost-Effectiveness in Health and Medicine in 1996, researchers have advanced methods of cost-effectiveness analysis (CEA), and policy makers have experimented with its application. In this session, members of the Panel will present the recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine, highlighting key areas of change from the original Panel’s report. The Second Panel endorses the original Panel’s concept of a “Reference Case” or set of standard methodological practices that all CEAs should follow to improve quality and comparability. However, the Second Panel reconsidered issues surrounding the appropriate perspective of the Reference Case and recommends that all CEAs report two Reference Case analyses: one based on a healthcare sector perspective and one based on a societal perspective. The Second Panel also recommends an “Impact Inventory,” intended to clarify the scope and boundaries of the two Reference Case analyses. The session will provide an overview of these recommendations and others concerning the estimation of the costs and consequences of interventions, the valuation of health outcomes, and the reporting of CEAs. A full day conference on the Panel’s recommendations will be held December 7th at the National Academy of Sciences.

Anirban Basu, PhD
Pharmaceutical Outcomes Research and Policy Program, University of Washington
Director, Professor
Dept. of Health Services, School of Public Health

Anirban Basu is the Stergachis Family Endowed Professor and Director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington with additional appointments in the Department of Health Services, the Department of Economics and the National Bureau of Economic Research. Anirbanís work sits at the intersection of microeconomics, statistics, and health policy. His research focuses on comparative and cost effectiveness analyses, causal inference methods, program evaluation, and outcomes research, with a special emphasis on studying heterogeneity in clinical and economic outcomes in order to establish the realized and potential values of individualized care. Anirban is as an associate editor for Observational Studies, and in the past of Health Economics and the Journal of Health Economics. He served on the Second Panel on Cost-effectiveness in Health and Medicine. He is a past recipient of the ISPOR Methodology Awards and the Bernie OíBrien New Investigator Award. He is an elected Fellow of the American Statistical Association. Anirban has a Bachelorís degree from India, a Masters in Biostatistics from the UNC, Chapel Hill, and a PhD in Public Policy with a concentration in health economics from the University of Chicago

David Feeny, PhD
McMaster University

Murray Krahn, MD, MSc, FRCPC
Toronto Health Economics and Technology Assessment (THETA) Collaborative
Director and Professor

Murray Krahn is the founding director of the Toronto Health Economics and Technology Assessment Collaborative. He is a general internist at the University Health Network in Toronto, and has a long research interest in decision making in health, both at the individual and health policy level. He has published widely in health preference and cost measurement, decision analysis, and health technology assessment. He has been President of the Society for Medical Decision Making (2013-4), and has won lifetime research achievement awards from CADTH, the Canadian Society for Internal Medicine, and the Association of Faculties of Pharmacy of Canada. Member of both the Canadian and US Panels on guidelines for cost effectiveness analysis, he has trained a significant number of the academic leaders in HTA in Canada.

Karen M. Kuntz, ScD
University of Minnesota School of Public Health
Health Policy and Management

David O. Meltzer, MD, PhD
University of Chicago
Professor of Medicine
Section of Hospital Medicine

Douglas K. Owens, MD, MS
VA Palo Alto Health Care System
Professor of Medicine
Veterans Affairs Palo Alto Health Care System and Center for Health Policy & Center for Primary Care and Outcomes Research and

Lisa A. Prosser, MS, PhD
University of Michigan, Child Health Evaluation and Research Center
Child Health Evaluation and Research Unit

Joshua A. Salomon, PhD
Harvard School of Public Health
Professor of Global Health
Department of Global Health and Population

Thomas Trikalinos, MD, PhD
Brown University
Associate Professor
Center for Evidence-based Medicine


Peter Neumann, ScD
Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
Tufts Medical Center

Gillian D. Sanders, PhD
Duke University School of Medicine
Associate Professor